Introduction
============

Plasmodesmata (PD) provide a symplastic connection between neighboring cells in plants and thereby enable the selective transport of assimilates and macromolecules (Ding, [@B6]; Roberts and Oparka, [@B30]; Lucas et al., [@B24]). Many plant viruses encode for one or more movement protein (MPs), which facilitate cell-to-cell transport of viral ribonucleoprotein complexes or viral particles to and through PD by interacting with host factors thus enabling viral cell-to-cell and systemic spread (Lazarowitz and Beachy, [@B20]). While the structure of MPs among different plant virus families is not conserved and apparently different strategies for PD targeting are employed, it is well established that most of these proteins can increase the basal size exclusion limit (SEL) of PD and move through PD in a non-cell-autonomous manner (Wolf et al., [@B45]; Waigmann et al., [@B44]; Haywood et al., [@B10]; Taliansky et al., [@B35]). Importantly, several MPs have been shown to be phosphorylated by plasma membrane- or ER-localized kinases (Citovsky et al., [@B5]; Matsushita et al., [@B26], [@B27]; Waigmann et al., [@B42]; Karger et al., [@B15]; Módena et al., [@B28]). Mimicking this modification of *tobacco mosaic virus* (TMV) MP30 by substitution of phosphorylated amino acids with aspartate severely hampered PD targeting, SEL modification, and viral spread (Waigmann et al., [@B42]; Karger et al., [@B15]).

While most studies focused on TMV MP30, little is known about the importance of posttranslational modifications of other viral MPs for PD targeting and virus infection. Here we report on PLRV--MP17, which can be functionally expressed in Arabidopsis plants (Kronberg et al., [@B19]). MP17 localizes to and modifies SEL of secondary branched PD in source tissues, but does not target structural dissimilar simple PD in s*ink* tissues (Hofius et al., [@B13]; Kronberg et al., [@B19]; Vogel et al., [@B40]). Unlike TMV MP30, the protein is transported via the ER-Golgi network to PD (Hofius et al., [@B13]; Vogel et al., [@B40]). Previous studies showed RNA-binding and protein phosphorylation of MP17, but the phosphorylation sites have not been identified (Tacke et al., [@B33], [@B34]; Sokolova et al., [@B32]). Using MP17 deletion mutants fused to C-terminal GFP we show that the C-terminal part of MP17 is essential but not sufficient for PD localization. Analyzing the *in vivo* protein phosphorylation of MP17 expressed in Arabidopsis by mass-spectrometry revealed four phosphorylated serines. Site-directed mutagenesis demonstrated that S71 and/or S79 are essential for PD targeting of MP17.

Materials and Methods
=====================

Cloning, stable, and transient plant transformation
---------------------------------------------------

The coding sequence of MP17 was fused C-terminally with six histidine residues by conventional PCR amplification (from plasmid p35S-1; Hofius et al., [@B13]; primer see Table [2](#T2){ref-type="table"}) and inserted in pBinAR (Höfgen and Willmitzer, [@B12]) via Asp718/BamHI to create plasmid MP17--PMH. Transformation of Arabidopsis Columbia-0 was carried out as described (Kronberg et al., [@B19]).

Different mutations were introduced in the MP17 sequence by overlap PCR with specific primers (Table [2](#T2){ref-type="table"}) or deletion variants were obtained by PCR with respective primers. Mutagenized DNA fragments were first subcloned into the pENTR directional TOPO vector (Invitrogen) followed by LR reaction into the destination vector pK7FWG2 using LR clonase enzyme to create C-terminal GFP fusions (Invitrogen). The resulting fusion proteins were transiently expressed in 4--6 weeks old *Nicotiana benthamiana*via agroinfiltration (Voinnet et al., [@B41]). Two days after infiltration, localization was analyzed by Confocal Laser Scanning Microscopy using a TCS SP5 (Leica; Bensheim). Propidium iodide staining and excitation/detection of emission were conducted as described (Vogel et al., [@B40]).

Affinity purification of MP17:HIS
---------------------------------

As previously described for the enrichment of MP30 in cell wall fractions (Citovsky et al., [@B5]), MP17 is closely attached to the cell wall/plasma membrane at PD and cannot be solubilized by mild detergents offering a method to remove soluble proteins from the cell wall/MP17:HIS fraction and minimize unspecific purification of host proteins. Thus rosettes of transgenic Arabidopsis plants were ground and homogenized in Nonidet P40 (NP40) buffer (2% NP40\[v/v\]; 100 mM Tris pH 8.0; 10 mM DTT; 5 mM EDTA; 150 mM NaCl; 1:100 \[v/v\] phosphatase inhibitor cocktail I and II; \[Sigma\]; protease inhibitor complex \[Roche\]; 5 μM E-64 \[Sigma\]). After centrifugation (15,000 × *g*, 15 min, 4°C), the resulting pellet was washed four times with NP40-buffer. Then the pellet was mixed 3:1 (w/v) with urea-buffer (8 M urea; 0.1 M NaH~2~PO~4~, 0.01 M Tris, pH 8.0) and incubated at 37°C for 45 min following centrifugation at room temperature. The corresponding eluate was used for affinity purification with Nickel-NTA (ProBond Resin; Invitrogen). After incubation (75 min at room temperature), beads were washed three times with urea-buffer at pH 6.3. Bound proteins were eluted with urea-buffer at pH 6.3 added with 100 mM EDTA.

SDS-page and western blotting
-----------------------------

Proteins were precipitated for 30 min at −20°C after adding four volumes ice cold Methanol/Chloroform (2:1 v/v). Following drying, proteins were directly dissolved in 2× SDS loading buffer (Hofius et al., [@B13]) and separated on a 12.5% gel (acrylamide/piperazin diacrylamide) by discontinuous electrophoresis (Schmidt et al., [@B31]). Fixation and staining with colloidal coomassie was conducted according to the manufactures instructions (Sigma).

Proteins were separated on 12.5% (v/v) SDS-polyacrylamid gels and transferred to nitrocellulose membrane (Porablot). Immunoreaction was carried out using anti-MP17 antiserum as described before (Hofius et al., [@B13]).

Mass spectrometry
-----------------

MP17:HIS bands were cut with a scalpel and gel slices reduced, alkylated, and digested with trypsin (Catrein et al., [@B4]) using a Digest pro MS liquid handling system (Intavis AG, Germany). Following digestion, tryptic peptides were extracted from the gel pieces with 50% acetonitrile/0.1% TFA, concentrated nearly to dryness in a speed Vac vacuum centrifuge and diluted to a total volume of 30 μl with 0.1% TFA. Optionally, tryptic peptides were digested additionally after gel extraction with chymotrypsin before further processing. The samples (each 25 μl) were analyzed by a nanoHPLC system (Eksigent) coupled to a ESI LTQ Orbitrap (Thermo Fisher) mass spectrometer (Tegha-Dunghu et al., [@B37]). One survey scan (res: 30,000) was followed by three information dependent product ion scans in the Orbitrap (res: 15,000) and 2+, 3+, and 4+ charged ions were selected for fragmentation.

The MS/MS spectra were searched against a small protein database containing the MP17 sequence using the Mascot software (Perkins et al., [@B29]). The algorithm was set to use no enzyme specificity, assuming carbamidomethyl as a fixed modification of cysteine, and oxidized methionine and deamidation of asparagines and glutamine as variable modifications. Phosphorylation of serine, threonine, and tyrosine was also set to variable modification and mass tolerance was set to 1.1 or 0.1 Da for MS and MS/MS, respectively. Each phosphopeptide found by the software was further inspected by manual interpretation of the fragment spectrum.

λ-phosophatase incubation
-------------------------

Purified MP17:HIS eluate was dialyzed gradually to 50 mM Tris/Cl pH 6.8 and subsequently 10 μl were incubated with or without 400 units λ-Phosphatase (New England Biolabs, Ipswich, USA) for 60 min at 30°C. For evaluation of mobility shift, proteins were separated by SDS-PAGE (15% acrylamide/bisacrylamide) and MP17 was detected by the anti-MP17 antiserum as described above.

Alignment of luteoviral MPs
---------------------------

Protein sequences of luteoviral MPs homologous to PLRV--MP17 were aligned with "ClustalW2"[^1^](#fn1){ref-type="fn"}. Accession numbers: AAB70926.1 (*barley yellow dwarf virus)*; AAF62534.1 (*cereal yellow dwarf virus)*; AAK49962.1 (*beet chlorosis virus)*; AAM22679.1 (*beet western yellows virus)*; AAZ57428.1 (*beet mild yellowing virus*); AAX08105.1 (*cotton leaf roll dwarf virus)*; ACA04435.1 (*soybean dwarf virus)*; ABG46340.1 (*sweet potato leaf speckling virus)*.

Results
=======

Deletion analysis of MP17
-------------------------

To start analysis of MP17 PD targeting, we tested intracellular localization of different deletion variants of the protein (Figure [1](#F1){ref-type="fig"}). To this end, MP17 variants were fused at their C-terminus to GFP, transiently expressed in *N. benthamiana* leaf epidermal cells via *Agrobacterium*-mediated gene transfer and imaged by confocal microscopy. In a previous study (Hofius et al., [@B13]) PD localization of MP17:GFP was verified by immuno-EM localization of GFP and MP17, respectively. According to "GlobPlot"[^2^](#fn2){ref-type="fn"}, there are three disordered domains (Figure [1](#F1){ref-type="fig"}, DD I, II, and III) within MP17, which might be putative functional domains (Linding et al., [@B22]).

![**MP 17 deletion variants**. Schematic overview of MP 17 protein structure with disordered (black) or globular domains \[middle gray\] according to "GlobPlot" and intracellular localization of the respective C-terminal GFP fusion proteins. The wild-type MP 17 depicts the areas of disordered domain 1 (DDI; aa 5--18), DDII (aa 30--37), DDIII (aa 110--143), the positions of the four phosphorylated serines and the putative domains for homodimerization (HD; aa 38--54) and nucleic acid binding (NBD; aa 57--156).](fpls-02-00018-g001){#F1}

Therefore, we deleted separately 18 aa of the N-terminus (MP17Δ1-18) or 57 aa of the C-terminus (MP17Δ110-156), corresponding to the predicted disordered domains DD I and DD III. While MP17Δ1-18 was still targeted to PD, MP17Δ110-156 localized in the nucleus and the cytoplasm (Figure [2](#F2){ref-type="fig"}A). To test whether the C-terminus is sufficient for PD targeting, the C-terminus was fused to GFP (MP17Δ1-109) and tested for PD localization. As shown in Figure [2](#F2){ref-type="fig"}A the MP17Δ1-109 GFP fusion protein did not target to PD but accumulated in the cytoplasm and nucleus. As this might be due to incorrect folding and/or missing additional amino acids, we prolonged the C-terminal part in several steps. Surprisingly, extension with 10, 20, or 30 aa (MP17Δ1-99, MP17Δ1-89, MP17Δ1-79) resulted in chloroplast targeting of GFP (Figures [2](#F2){ref-type="fig"}A, B). Analyzing the N-terminus of these fusion proteins by "ChloroP" revealed the presence of predicted chloroplast transit peptides[^3^](#fn3){ref-type="fn"} (Score: 0,534 for MP17Δ1-99, 0,545 for MP17Δ1-89, and 0,522 for MP17Δ1-79). Subsequent extensions abolished chloroplast targeting and led to accumulation of GFP in the cytoplasm and the nucleus. Only deletion variant MP17Δ1-27, lacking the first 27 N-terminal amino acids of MP17, was efficiently targeted to PD (Figure [2](#F2){ref-type="fig"}A).

![**Intracellular localization of MP17 deletions**. Confocal images of MP 17 deletion variants fused to C-terminal GFP after transient expression in *N. benthamiana*; **(A)** superimpositions of MP17:GFP fluorescence in green with propidium iodide stained cell walls/nuclei in red in epidermal cells; **(B)** single images and merge (right) of green MP17:GFP fluorescence and blue chlorophyll auto fluorescence in mesophyll cells; bars represents 20 μm.](fpls-02-00018-g002){#F2}

As this mutant protein still contains many putative phosphorylation sites, which are potential targets for various protein kinases, we next went for direct identification of phosphorylated residues by mass-spectrometry.

*In vivo* phosphorylation of MP17 in arabidopsis
------------------------------------------------

MP17 was fused to a C-terminal 6× histidine-tag (MP17:HIS, Figure [3](#F3){ref-type="fig"}A) to enable affinity purification and subsequently introduced into *Arabidopsis thaliana* by *Agrobacterium*-mediated gene transfer. Following transformation one Arabidopsis line (AtPMH2) showing high expression of the fusion protein, as confirmed by Western analysis (Figure [4](#F4){ref-type="fig"}C), was selected for further analysis. The fusion protein was detectable in SDS-PAGE at 21--22 kDa (Figure [4](#F4){ref-type="fig"}C) in contrast to a calculated mass[^4^](#fn4){ref-type="fn"} of 18.2 kDa.

![**Stable expression of MP17:HIS in Arabidopsis**. **(A)** Schematic drawing of the MP17:HIS fusion construct containing C-terminal six histidine residues; **(B)** ATPMH2 plants (right) showing chlorotic source leaves and stunted growth as compared to wild type (left); bar shows 2 cm.](fpls-02-00018-g003){#F3}

![**Affinity purification of MP17:HIS**. **(A)** Purification strategy of MP17:HIS; ATPMH2 rosettes were homogenized in NP40-buffer and soluble (1) and insoluble fractions were separated by centrifugation; the insoluble fraction was washed four times to reduce unspecific binding (last supernatant = 2); the insoluble fraction was subsequently extracted with urea and the urea insoluble (3) and soluble fraction (4) were separated by centrifugation; the soluble fraction was used for affinity purification on Nickel-NTA resin; fraction 5 represents the flow through and fraction 6 the last wash; bound proteins were eluted with EDTA (7); **(B)** Aliquots of the indicated purification steps (1--7) were separated by SDS-PAGE and stained with colloidal coomassie; **(C)** MP17:HIS (arrows) was detected by immuno blotting using anti-MP17-antiserum; WT = wild type protein extract.](fpls-02-00018-g004){#F4}

AtPMH2 plants were characterized by stunted growth and chlorotic source leaves (Figure [3](#F3){ref-type="fig"}B). This phenotype is reminiscent of MP17 transgenic tobacco or Arabidopsis plants (Herbers et al., [@B11]; Hofius et al., [@B13]; Kronberg et al., [@B19]), confirming functionality of the MP17:HIS fusion protein.

For purification of MP17:HIS, soluble proteins were removed using a mild detergent and subsequently MP17:HIS was solubilized with 8 M Urea and affinity purified (Figures [4](#F4){ref-type="fig"}A--C). To verify *in vivo* phosphorylation of MP17:HIS, the protein was incubated with λ-Phosphatase, and the shift in mobility was analyzed by SDS-PAGE. As seen in Figure [5](#F5){ref-type="fig"}, phosphatase treated MP17:HIS migrates faster in SDS-PAGE, indicating *in vivo*phosphorylation of the protein (Figure [5](#F5){ref-type="fig"}).

![**Treatment of MP17:HIS with λ-Phosphatase**. Purified MP17:HIS was incubated with (+) or without (−) λ-Phosphatase and gel migration was monitored by SDS-PAGE following immunological detection of MP17:HIS; probes are duplicates; WT, wild type crude extract.](fpls-02-00018-g005){#F5}

Identification of phosphorylation sites by MS/MS
------------------------------------------------

Following SDS-PAGE, MP17:HIS was cut out of the gel and *in gel* digested with trypsin. Extracted peptides were analyzed by nano LC-ESI-MS/MS. Data evaluation with "MASCOT"[^5^](#fn5){ref-type="fn"} identified 16 unique MP17-specific peptides, of which three showed phosphorylation at different serine residues -- S71, S79, and S137 (see Table [1](#T1){ref-type="table"}). As no peptides corresponding to the N-terminal part of MP17 were identified due to the lack of trypsin cleavage sites, extracted peptides after trypsin digestion were subjected to an additional cleavage with chymotrypsin. This yielded 20 additional peptides, giving a total peptide coverage of 73.3% of the MP17 polypeptide. Analysis of these peptides confirmed the three initially identified phosphorylation sites, along with a fourth one at S140 (Figure [1](#F1){ref-type="fig"}).

###### 

**Phosphorylated MP17 peptides**.

  Position \[aa\]   Score   Sequence                Digestion
  ----------------- ------- ----------------------- ----------------------
  69--76            42      R.TT**S**WATPK.E        Trypsin
  77--89            33      K.EV**S**PSGRVYQTVR.H   Trypsin
  133--144          46      K.YHPS**S**PTSTSSK.L    Trypsin
  69--76            32      R.TT**S**WATPK.E        Trypsin/chymotrypsin
  77--85            27      K.EV**S**PSGRVY.Q       Trypsin/chymotrypsin
  133--144          24      K.YHPS**S**PTSTSSK.L    Trypsin/chymotrypsin
  133--144          21      K.YHPSSPT**S**TSSK.L    Trypsin/chymotrypsin

*Sequence of identified MP17-phosphopeptides (after digestion with trypsin alone or trypsin followed by incubation with chymotrypsin) is separated from flanking amino acids by dots and phosphorylated serines are given in bold; score-values calculated by MASCOT \[Score = -10 × Log(p)\] are a means of expressing probability p that a match of theoretical and observed mass is by chance, where a score of 20 accounts for p ≤ 0.01*.

###### 

**Primer used in this study**.

  Construct                 Primer   Sequence 5\'--3\'
  ------------------------- -------- -------------------------------------------------------------------------------
  MP17-PMH                  FV17     GGTACCATGTCAATGGTGGTGTACAACAACC
                            FV20     TATAGGATCCTCA*GTGATGGTGATGGTGATG*TCCGCGCTTGATAAGTTTTGGC
  **DELETIONS**                      
  MP17fl                    KL1      CACCAACAATGTCAATGGTGGTGTACAACAACCAAGG
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Δ 1-18                KL3      CACCAACAATGGGCGCGCTAACAGAGTTCAGCC
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Δ 110-156             KL1      CACCAACAATGTCAATGGTGGTGTACAACAACCAAGG
                            KL4      GAAGTAAGATGCTTGTGATCTTATACTCATGG
  MP17Δ 1-109               KL7      CACCAACAATGAGTTCGTCAGCGAGG
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Δ 1-99                KL20     CACCAACAATGATGAGTATAAGATCACAAGCATCTTACTTC
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Δ 1-89                KL21     CACCAACAATGCATTCAAGGATGGAATACTCAAGGC
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Δ 1-79                KL22     CACCAACAATGCCTTCGGGCCGAGTCTATCAG
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Δ 1-66                KL23     CACCAACAATGCAAAGGACAACCTCATGGGCAAC
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Δ 1-53                KL24     CACCAACAATGTTCCCCGAGGACGAGGC
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Δ 1-40                KL25     CACCAACAATGGTAGAAGAGGAGGCAATCGCCG
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Δ 1-27                KL26     CACCAACAATGTTATGGTCACGGCCTCTGGG
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  **SUBSTITUTIONS**                  
  MP17A69-81 A              KL1      CACCAACAATGTCAATGGTGGTGTACAACAACCAAGG
                            KL28     AGTCTGATAGACTCGGCCCGCAGGTGCAACTTCCTTGGGAGCTGCCCATGCGGCTGCCCTTTGTAAACACGAATGTC
  MP17A69-81 B              KL27     GACATTCGTGTTTACAAAGGGCAGCCGCATGGGCAGCTCCCAAGGAAGTTGCACCTGCGGGCCGAGTCTATCAGACT
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17A136-143 A            KL1      CACCAACAATGTCAATGGTGGTGTACAACAACCAAGG
                            KL13     CGCCGCCCTTCGTAATTTGGCAGCCGCGGCCGCAGGAGCGGCGGGATGATACTTTGCAATGGG
  MP17A136-143 B            KL12     CCCATTGCAAAGTATCATCCCGCCGCTCCTGCGGCCGCGGCTGCCAAATTACGAAGGGCGGCG
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Aall                           Template MP17A136-143, primers as MP17A69-81
  MP17D71 A                 KL1      CACCAACAATGTCAATGGTGGTGTACAACAACCAAGG
                            KL30     CTTGGGAGCTGCCCAGTCGGCTGCCCTTTGTAA
  MP17D71 B                 KL29     TTACAAAGGGCAGCCGACTGGGCAGCTCCCAAG
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17D79 A                 KL1      CACCAACAATGTCAATGGTGGTGTACAACAACCAAGG
                            KL32     GACTCGGCCCGCAGGGTCAACTTCCTTGGGAGC
  MP17D79 B                 KL31     GCTCCCAAGGAAGTTGACCCTGCGGGCCGAGTC
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17D7179                          template MP17D71, primers as MP17D79
  Primer to merge A and B   KL1      CACCAACAATGTCAATGGTGGTGTACAACAACCAAGG
                            KL2      TCCGCGCTTGATAAGTTTTGGC
  MP17Δ110-156D71                    template MP17D71, primers as MP17Δ 110-156

Topo directional site and enhancer sequence are underlined, triplets encoding for six histdines are written in italic

Functional analysis of phosphorylated serines
---------------------------------------------

In order to analyze the importance of these phosphorylation sites for PD targeting of MP17, we exchanged the respective serine residues to alanine. However, there are not only two pairs of serines close to each other but also additional putative phosphorylation sites (serine, threonine) in their vicinity which could potentially be phosphorylated instead of the detected modified residues when exchanging these one by one. Thus we swapped all serines/threonines neighboring the two phosphorylation site pairs to alanine as depicted in Figure [6](#F6){ref-type="fig"}A. Alanine substitution at the C-terminal pair had no influence on PD targeting (MP17A136-143; Figure [6](#F6){ref-type="fig"}C). In contrast, alanine exchanges at the center pair abolished PD localization and resulted in highly movable aggregates in the cytoplasm (MP17A69-81; Figure [6](#F6){ref-type="fig"}B; **Movie S1** in Supplementary Material). The same was observed for exchanges of both pairs (MP17Aall; Figure [6](#F6){ref-type="fig"}D).

![**Impact of MP17 phosphorylation on PD targeting**. **(A)** Amino acid changes introduced in the mutated MP 17 versions compared to wild type MP 17, position of exchanged peptides is indicated within the MP 17 polypeptide; **(B--G)** confocal images of the respective MP17:GFP variants transiently expressed in *N. benthamiana* epidermis cells; displayed are superimpositions of propidium iodide stained cell walls (red) and MP17:GFP fluorescence (green); bars represent 20 μm.](fpls-02-00018-g006){#F6}

Consequently, we substituted specifically S71, S79 or both on basis of the alanine-swap variant MP17Aall to aspartate (Figure [6](#F6){ref-type="fig"}A) to mimic phosphorylation as already done for MP analysis before (Waigmann et al., [@B42]). Aspartate substitution of either S71 (MP17D71, Figure [6](#F6){ref-type="fig"}E) or S79 (MP17D79, Figure [6](#F6){ref-type="fig"}F) was sufficient to restore PD targeting of MP17. Consequently, restoration of PD localization was also observed when substituting both S71 and S79 to aspartate (MP17D7179, Figure [6](#F6){ref-type="fig"}G). Thus a negative charge generated by phosphorylation at S71 or S79 in this central region seems to be essential for MP17 PD localization.

Possibly, the truncated MP17Δ110-156 lacking the C-terminus might not be properly folded and therefore might not be a substrate for protein kinase(s), which would explain its inability to target PD due to its missing phosphorylation at S71/S79 rather than due to an essential role of the C-terminus itself. To test this possibility, we introduced an aspartate substitution at S71 in the MP17Δ110-156 deletion variant (MP17Δ110-156D71). CLSM analysis of the resulting protein revealed accumulation in the nucleus and the cytoplasm (Figure [7](#F7){ref-type="fig"}).

![**Substitution of S71 by aspartate does not compensate loss of C-terminus**. Confocal images of MP17 **(A)** or MP17Δ110-156D71 **(B)**fusions in *N. benthamiana* epidermis cells; displayed are superimpositions of propidium iodide stained cell walls (red) and MP17:GFP fluorescence (green); bars represent 20 μm.](fpls-02-00018-g007){#F7}

Because phosphorylation at S137/S140 is not essential for PD targeting, we checked the presence of all four serines in other luteoviral MPs. Sequence alignment of MP17 with MPs of eight additional luteoviruses showed that S71 and S79 are highly conserved corresponding to their importance (Figure [8](#F8){ref-type="fig"}). In contrast, S137 is unique for PLRV--MP17, while S140 is present only in some but not all luteoviral MPs.

![**Sequence alignment of MPs of different luteoviruses**. Phosphorylation sites identified in PLRV--MP17 are highlighted in yellow.](fpls-02-00018-g008){#F8}

Discussion
==========

Viral MP perform -- same as many other viral proteins -- different tasks. They not only bind the viral genome and facilitate PD targeting of the respective ribonucleoprotein complexes, but also modify the plasmodesmal SEL to enable viral cell-to-cell and systemic spread (Lucas, [@B23]). Extensive studies using various techniques have been performed on the model protein TMV MP30. This includes early studies on the ability of MP30 deletion mutants to target PD and ranges to functional analysis of mutants obtained by DNA shuffling or recent data concerning *in vivo* oligomerization of MP30 using fluorescence lifetime imaging microscopy (FLIM; Berna et al., [@B2]; Gillespie et al., [@B7]; Boutant et al., [@B3]).

In contrast, there is little information about functional domains in the PLRV--MP17. Early deletion analysis confirmed that the C-proximal part (aa 57--156) confers nucleic acid binding activity and site directed mutagenesis revealed a putative N-terminal amphipathic alpha-helix (aa 38--54) essential for MP17 *in vivo* dimerization (Tacke et al., [@B33], [@B34]; Karger et al., [@B15]). However, functional analysis of MP17 PD targeting has not been described until now.

PD targeting of MP17 deletion mutants
-------------------------------------

Based on deletion analysis we were able to demonstrate that the C-terminus (aa 110--156) of PLRV--MP17 is essential but not sufficient for PD targeting. PD targeting motifs have been tested before in a similar way. For example the transmembrane domain of plasmodesmata localized protein 1a (PDLP1a) enables PD localization of a respective YFP fusion protein (Thomas et al., [@B38]). In contrast, a short sequence within pumpkin phloem heat shock cognate 70-1 (HSC70-1) essential for cell-to-cell transport is not sufficient to enable transport through PD when fused to GFP but in a heterochimeric fusion with human heat shock protein 70 (Aoki et al., [@B1]), indicating the need for an additional motif and/or correct secondary structure.

Subsequent deletions revealed that the shortest version of MP17 still targeting PD lacked only the first 27 aa. This might either indicate that shorter deletion variants are not properly folded or rather a second targeting signal within DD II (aa 30--37) is necessary for PD localization.

Surprisingly, our deletion analysis revealed also hidden chloroplast transit peptides. Whether these structural features have biological significance remains unknown. Testing the presence of potential chloroplast transit peptides at the N-terminus of 4002 *E. coli* K12 proteins revealed 163 candidates with scores between 0.5 and 0.56 (Heinrich Sticht, personal communication). This finding might indicate widespread occurrence of potential targeting signals and suggest no specific role for virus MP.

Phosphorylation of MP17 is essential for PD localization
--------------------------------------------------------

Phosphorylation of viral MPs has been shown in the past to influence their function and localization (Lucas and Lee, [@B25]). This is not limited to MPs, as illustrated by the finding that phosphorylation of the *potato virus a* capsid protein is essential for virus systemic spread (Ivanov et al., [@B14]). Moreover, also a pumpkin *non cell autonomous protein*, *Cucurbita maxima* phloem protein 16 (CMPP16), needs to be phosphorylated in order to modify plasmodesmal SEL (Taoka et al., [@B36]), indicating a general mechanism involving phosphorylation of proteins trafficking within the plasmodesmal pathway.

By mass spectrometry we identified four phosphorylation sites. Mutant analysis revealed that two of these (S71 and S79) are essential for PD targeting, while mutation of the C-terminal phosphorylation sites did not alter PD targeting of the mutant protein. Similar studies have been carried out with TMV MP30 and *tomato mosaic virus* MP to analyze the importance of phosphorylation for MP functionality and PD targeting (Kawakami et al., [@B18]; Waigmann et al., [@B42]; Karger et al., [@B15]; Trutnyeva et al., [@B39]). Based on these results we can conclude that PD targeting of MP17 required at least two domains, the C-terminus and the central phosphorylation sites.

Disruption of S71/S79 phosphorylation by alanine substitution lead to the formation of MP17:GFP aggregates of various size moving within the cytoplasm and also to/along the cell periphery (MP17A69-81, **Movie S1** in Supplementary Material). This might imply that transport to PD is not completely impaired and instead S71/S79 phosphorylation is essential for stable PD association. The nature of the observed aggregates is unknown. However, they vary in size and shape and directional trafficking could not be observed. Similar structures have been described by Grefen et al. ([@B8]) comparing the localization of SYP121--GFP fusion proteins expressed under control of the 35S-CaMV promoter. Since these structures were not observed if the same fusion protein was expressed under control of the UBQ10 promoter, the authors conclude that the observed mobile punctuated structures may represent inclusion bodies caused by the strong overexpression using the 35S-CaMV promoter. Therefore, we believe that it is unlikely that the aggregates observed in our study represent structures of the normal PD trafficking route of MP17:GFP.

In agreement with the detection and functional requirement of S71/S79, MP17 was described before to be phosphorylated in the region of aa 55--95. These results were obtained *in vitro* by expression of truncated versions of MP17 in *E. coli* and subsequent incubation with potato membrane preparations or protein kinases (Sokolova et al., [@B32]). However, Sokolova et al. ([@B32]) detected no *in vitro* phosphorylation in other parts of the polypeptides including S137/S140.

Detailed analysis of MP30 implicates that initial phosphorylation increases its ability to target PD, while subsequent phosphorylation, possibly during PD passage, leads to its dissociation from PD (Trutnyeva et al., [@B39]). In addition, it was reported that TMV MP30 ribonucleoprotein complexes are translatable *in vivo*, but not *in vitro* unless they are phosphorylated (Karpova et al., [@B16], [@B17]). This might indicate that passage through PD and concomitant phosphorylation contribute to dissociation of the MP from the viral RNA genome, which in turn enables translation of viral RNA (Karpova et al., [@B17]; Waigmann and Citovsky, [@B43]; Trutnyeva et al., [@B39]). Thus there may be sequential phosphorylation of viral MPs, first enabling cell-to-cell transport of viral ribonucleoprotein complexes and second releasing viral RNA in an adjacent cell. Removing the MP from PD allows the host to regain control over plasmodesmal transport (Trutnyeva et al., [@B39]). In accordance with this, all four phosphorylated residues of MP17 are present within the previously identified nucleic acid binding domain of the protein (Tacke et al., [@B33]; Figure [1](#F1){ref-type="fig"}).

As phosphorylation of MP17 deletion variants was tested with membrane preparations by Sokolova et al. ([@B32]), phosphorylation of S137 and S140 may have been overlooked since their phosphorylation might occur during PD-mediated transport, which could not be assayed *in vitro*. This idea is supported by bioinformatic analysis which predicts S140 to be a target of a Casein-kinase I -- type kinase (consensus S/T/Y^P^X~1--2~S/T), which targets serine/threonine when preceded N-terminally by another phosphorylated residue (serine/threonine/tyrosine, which would be supplied by phosphorylation of S137) and spaced by one or two amino acids (Gross and Anderson, [@B9]). Interestingly, an Arabidopsis kinase of this type, PLASMODESMATA ASSOCIATED PROTEIN KINASE 1, was localized to PD and shown to phosphorylate TMV MP30 along with other *non cell autonomous proteins*(Lee et al., [@B21]).

In accordance with the idea of a sequential phosphorylation of viral MPs, our results support the theory that this is also true for MP17. First, MP17 is phosphorylated at S71/79 to enable PD targeting. Apparently, also the C-terminal aa 110--156 and a N-terminal domain (possibly within DD II of aa 30--37) are essential for PD targeting, but act only in conjunction with phosphorylation of serines S71/S79.

In contrast, phosphorylation at S137/S140 might occur later at/in PD causing the breakup of the ribonucleoprotein complex formed by MP17 and its cargo, the viral RNA genome. Based on sequence homology, S71/S79 are highly conserved among luteoviral MPs, but S140 is only present in some of the tested MPs and S137 is unique for MP17. If the assumption that S137/S140 are phosphorylated at/in PD and are essential for viral spread, this could indicate that these modifications are involved in determining host specificity. In accordance with this hypothesis, mimicking phosphorylation of TMV MP30 negatively effected its ability to modulate plasmodesmal SEL in *Nicotiana tabacum*, but not in *N. benthamiana*(Waigmann et al., [@B42]).

Conclusion
==========

In summary, MP17 localization depends not on one distinct domain but is facilitated by the co-operation of three parts of the protein indicating a complex folding and/or a highly sophisticated domain architecture within the MP17 protein.

Further analysis of MP17 deletion mutants as well as variants with alanine/aspartate substitutions regarding SEL modification and RNA binding activity will give new insights in MP17 functional domain organization in the future.
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